E. Michael Murphy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
E. Michael Murphy has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Jennifer Lin Rodis
The Ohio State University College of Pharmacy, 500 W. 12(th) Ave., Columbus, OH 43210
2 shared publications Anne Burns
College of Pharmacy, The Ohio State University, Columbus, OH
1 shared publicationArmando Silva Almodovar
PharmPix Corporation, San Juan, PR, USA
1 shared publicationBella Blankenship
Division of Pharmacy Practice and Science, The Ohio State University College of Pharmacy, Columbus, OH, USA
1 shared publication- Bella Blankenship1 shared publication
- Catherine G. Collins1 shared publication
Latest Publications
- Open Access
- 17 October 2026
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 67 (1)
Descriptive analysis of pharmacy closures and openings in the United States from 2022 to 2024
- 17 October 2026
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 67 (1)
Open AccessDescriptive analysis of pharmacy closures and openings in the United States from 2022 to 2024
- Open Access
- 29 July 2026
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 22 (12) , 1162-1168
Pharmacists through a public lens: Understanding trust, role recognition, and support for prescribing
- 29 July 2026
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 22 (12) , 1162-1168
Open AccessPharmacists through a public lens: Understanding trust, role recognition, and support for prescribing
- Open Access
- 21 May 2026
- Published by Oxford University Press (OUP) in Health Affairs Scholar
- Vol. 4 (6) , qxag126
Pharmacist participation as providers in Ohio Medicaid: an analysis of claims, services, and billing patterns, 2021-2025
Introduction: States increasingly recognize pharmacists as medical-benefit providers, yet participation under Medicaid is not well documented. Methods: We conducted a retrospective descriptive analysis of pharmacist-submitted claims to the Ohio Department of Medicaid from January 2017 to January 2025. Claims included current procedural terminology/International Classification of Diseases-10 codes, paid/denied status, payment amounts, and place of service. Results: Pharmacists submitted 1424 claims before implementation and nearly 250 000 afterward, with more than 85% paid and $4.4 million reimbursed. Most claims occurred in team-based settings (Federally Qualified Health Centers [55%] and office practices [41%]) while community pharmacy billing was rare (0.19%). Common services included evaluation and management visits, preventive counseling, and continuous glucose monitoring; leading diagnoses were type 2 diabetes, hypertension, and nicotine dependence. Conclusion: Recognition of pharmacists as medical-benefit providers produced rapid participation at modest cost, primarily in integrated clinical settings. These findings suggest that streamlined referral processes and improved billing support may expand participation, particularly in community pharmacies.
- 21 May 2026
- Published by Oxford University Press (OUP) in Health Affairs Scholar
- Vol. 4 (6) , qxag126
Open AccessPharmacist participation as providers in Ohio Medicaid: an analysis of claims, services, and billing patterns, 2021-2025
Introduction: States increasingly recognize pharmacists as medical-benefit providers, yet participation under Medicaid is not well documented. Methods: We conducted a retrospective descriptive analysis of pharmacist-submitted claims to the Ohio Department of Medicaid from January 2017 to January 2025. Claims included current procedural terminology/International Classification of Diseases-10 codes, paid/denied status, payment amounts, and place of service. Results: Pharmacists submitted 1424 claims before implementation and nearly 250 000 afterward, with more than 85% paid and $4.4 million reimbursed. Most claims occurred in team-based settings (Federally Qualified Health Centers [55%] and office practices [41%]) while community pharmacy billing was rare (0.19%). Common services included evaluation and management visits, preventive counseling, and continuous glucose monitoring; leading diagnoses were type 2 diabetes, hypertension, and nicotine dependence. Conclusion: Recognition of pharmacists as medical-benefit providers produced rapid participation at modest cost, primarily in integrated clinical settings. These findings suggest that streamlined referral processes and improved billing support may expand participation, particularly in community pharmacies.
- Open Access
- 31 January 2025
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 21 (5) , 321-331
Return on investment of pharmacists’ services among non-hospitalized patients: A scoping review
- 31 January 2025
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 21 (5) , 321-331
Open AccessReturn on investment of pharmacists’ services among non-hospitalized patients: A scoping review
- 30 June 2023
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 63 (6) , 1826-1838.e1
Optimizing patient outcomes: Health plans and pharmacists summit: Meeting proceedings
- 30 June 2023
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 63 (6) , 1826-1838.e1
Optimizing patient outcomes: Health plans and pharmacists summit: Meeting proceedings
- 24 January 2022
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 18 (9) , 3704-3709
Current issues and recommendations to manage prescription drug benefits for public health programs
- 24 January 2022
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 18 (9) , 3704-3709
Current issues and recommendations to manage prescription drug benefits for public health programs
- 1 September 2021
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 61 (5) , e41-e44
Politics, patients, and the role of the pharmacist: Addressing social and political issues that affect health care
- 1 September 2021
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 61 (5) , e41-e44
Politics, patients, and the role of the pharmacist: Addressing social and political issues that affect health care